These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 32618397)

  • 1. Hypermethylation of lncRNA MEG3 impairs chemosensitivity of breast cancer cells.
    Li H; Wang P; Liu J; Liu W; Wu X; Ding J; Kang J; Li J; Lu J; Pan G
    J Clin Lab Anal; 2020 Sep; 34(9):e23369. PubMed ID: 32618397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA MEG3 negatively modified osteosarcoma development through regulation of miR-361-5p and FoxM1.
    Shen B; Zhou N; Hu T; Zhao W; Wu D; Wang S
    J Cell Physiol; 2019 Aug; 234(8):13464-13480. PubMed ID: 30624782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non-coding RNA MEG3 functions as a tumour suppressor and has prognostic predictive value in human pancreatic cancer.
    Ma L; Wang F; Du C; Zhang Z; Guo H; Xie X; Gao H; Zhuang Y; Kornmann M; Gao H; Tian X; Yang Y
    Oncol Rep; 2018 Mar; 39(3):1132-1140. PubMed ID: 29328401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulated long noncoding RNA MEG3 is associated with poor prognosis and promotes cell proliferation in gastric cancer.
    Sun M; Xia R; Jin F; Xu T; Liu Z; De W; Liu X
    Tumour Biol; 2014 Feb; 35(2):1065-73. PubMed ID: 24006224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Linc-ROR induces epithelial-mesenchymal transition and contributes to drug resistance and invasion of breast cancer cells.
    Chen YM; Liu Y; Wei HY; Lv KZ; Fu P
    Tumour Biol; 2016 Aug; 37(8):10861-70. PubMed ID: 26883251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long noncoding RNA MEG3 inhibits breast cancer growth via upregulating endoplasmic reticulum stress and activating NF-κB and p53.
    Zhang Y; Wu J; Jing H; Huang G; Sun Z; Xu S
    J Cell Biochem; 2019 Apr; 120(4):6789-6797. PubMed ID: 30556250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The overexpression of hypomethylated miR-663 induces chemotherapy resistance in human breast cancer cells by targeting heparin sulfate proteoglycan 2 (HSPG2).
    Hu H; Li S; Cui X; Lv X; Jiao Y; Yu F; Yao H; Song E; Chen Y; Wang M; Lin L
    J Biol Chem; 2013 Apr; 288(16):10973-85. PubMed ID: 23436656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA HOTAIR-mediated MTHFR methylation inhibits 5-fluorouracil sensitivity in esophageal cancer cells.
    Zhang S; Zheng F; Zhang L; Huang Z; Huang X; Pan Z; Chen S; Xu C; Jiang Y; Gu S; Zhao C; Zhang Q; Shi G
    J Exp Clin Cancer Res; 2020 Jul; 39(1):131. PubMed ID: 32653028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Up-regulated lncRNA AFAP1-AS1 indicates a poor prognosis and promotes carcinogenesis of breast cancer.
    Ma D; Chen C; Wu J; Wang H; Wu D
    Breast Cancer; 2019 Jan; 26(1):74-83. PubMed ID: 29974352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of long noncoding RNA MEG3 is associated with poor prognosis and promoter hypermethylation in cervical cancer.
    Zhang J; Lin Z; Gao Y; Yao T
    J Exp Clin Cancer Res; 2017 Jan; 36(1):5. PubMed ID: 28057015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of long non-coding RNA MEG3 serves as an unfavorable risk factor for survival of patients with breast cancer.
    Zhang JJ; Guo SH; Jia BQ
    Eur Rev Med Pharmacol Sci; 2016 Dec; 20(24):5143-5147. PubMed ID: 28051255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. lncRNA MEG3 modified epithelial-mesenchymal transition of ovarian cancer cells by sponging miR-219a-5p and regulating EGFR.
    Wang L; Yu M; Zhao S
    J Cell Biochem; 2019 Oct; 120(10):17709-17722. PubMed ID: 31161607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Up-regulation of LncRNA MEG3 inhibits cell migration and invasion and enhances cisplatin chemosensitivity in bladder cancer cells.
    Feng SQ; Zhang XY; Fan HT; Sun QJ; Zhang M
    Neoplasma; 2018 Nov; 65(6):925-932. PubMed ID: 29940769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promoter hypermethylation influences the suppressive role of maternally expressed 3, a long non-coding RNA, in the development of epithelial ovarian cancer.
    Sheng X; Li J; Yang L; Chen Z; Zhao Q; Tan L; Zhou Y; Li J
    Oncol Rep; 2014 Jul; 32(1):277-85. PubMed ID: 24859196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA MEG3 inhibits cell epithelial-mesenchymal transition by sponging miR-421 targeting E-cadherin in breast cancer.
    Zhang W; Shi S; Jiang J; Li X; Lu H; Ren F
    Biomed Pharmacother; 2017 Jul; 91():312-319. PubMed ID: 28463794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long noncoding RNA MEG3 decreases the growth of head and neck squamous cell carcinoma by regulating the expression of miR-421 and E-cadherin.
    Ji Y; Feng G; Hou Y; Yu Y; Wang R; Yuan H
    Cancer Med; 2020 Jun; 9(11):3954-3963. PubMed ID: 32277605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA SNHG7 promotes development of breast cancer by regulating microRNA-186.
    Luo X; Song Y; Tang L; Sun DH; Ji DG
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7788-7797. PubMed ID: 30536320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-coding RNA LINC01287 promotes breast cancer cells proliferation and metastasis by activating Wnt/ß-catenin signaling.
    Song C; Sun P; He Q; Liu LL; Cui J; Sun LM
    Eur Rev Med Pharmacol Sci; 2019 May; 23(10):4234-4242. PubMed ID: 31173295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant Methylation-Mediated Silencing of lncRNA MEG3 Functions as a ceRNA in Esophageal Cancer.
    Dong Z; Zhang A; Liu S; Lu F; Guo Y; Zhang G; Xu F; Shi Y; Shen S; Liang J; Guo W
    Mol Cancer Res; 2017 Jul; 15(7):800-810. PubMed ID: 28539329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Long Noncoding RNA MEG3 Contributes to Cisplatin Resistance of Human Lung Adenocarcinoma.
    Liu J; Wan L; Lu K; Sun M; Pan X; Zhang P; Lu B; Liu G; Wang Z
    PLoS One; 2015; 10(5):e0114586. PubMed ID: 25992654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.